What is Clover Biopharmaceuticals, Ltd.’s 1-month forecast?

Meyka AI projects 2197.HK could trade near $1.96 in the next month, a move of -32.88% compared to today’s price.

What is Clover Biopharmaceuticals, Ltd.’s 1-year forecast?

By 2027, 2197.HK is forecasted to reach $4.53, reflecting a 55.29% change from the current level.

What is Clover Biopharmaceuticals, Ltd.’s 5-year forecast?

The 2030 projection for 2197.HK is $11.72, which represents a potential 301.46% change.

What is the 7-year outlook for Clover Biopharmaceuticals, Ltd.?

Over the next 7 years, 2197.HK could trade around $15.19, showing a 420.19% move from today’s price.

Can Clover Biopharmaceuticals, Ltd. (2197.HK) reach $17.6 by 2030?

Meyka AI’s 2030 forecast places 2197.HK at $11.72, making it unlikely to reach $17.6 by 2030 under current market conditions.

Clover Biopharmaceuticals, Ltd.

2197.HK•HKSE

Healthcare

Biotechnology

HK$2.92

HK$0.24(8.96%)

Hong Kong Market is Open • 11:49

Clover Biopharmaceuticals, Ltd. (2197.HK) Stock Forecast & Price Predictions

Get the latest Clover Biopharmaceuticals, Ltd. (2197.HK) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted PriceHK$1.96

Change↓ HK$-0.96 (-32.88%)

Quarterly Forecast

Predicted PriceHK$3.04

Change↑ HK$0.12 (4.11%)

Yearly Forecast

Predicted PriceHK$4.53

Change↑ HK$1.61 (55.29%)

3 Years Forecast

Predicted PriceHK$8.13

Change↑ HK$5.21 (178.57%)

5 Years Forecast

Predicted PriceHK$11.72

Change↑ HK$8.80 (301.46%)

7 Years Forecast

Predicted PriceHK$15.19

Change↑ HK$12.27 (420.19%)

Clover Biopharmaceuticals, Ltd. Stock Forecast Summary

Clover Biopharmaceuticals, Ltd. (2197.HK) stock is currently priced at $2.92. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $1.96.

In the long term, 2197.HK shows a bullish trend. The 2027 forecast points to $4.53 (55.29% change), while the 2031 forecast suggests $11.72 (301.46% change). Looking 7 years ahead, projections estimate the stock could trade near $15.19, a 420.19% change from today’s price.

Overall Sentiment

Neutral

Short-Term Outlook

Bearish

Long-Term Outlook

Bullish

This mix indicates that Clover Biopharmaceuticals, Ltd. stock is expected to rise steadily over the coming years.

Clover Biopharmaceuticals, Ltd. yearly Price Forecast Chart

Explore the yearly forecast chart for 2197.HK, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Clover Biopharmaceuticals, Ltd. over different timeframes.

No forecast data available

No prediction data found for this time period.

Forecasting data is not available for 2197.HKForecasting details for 2197.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Clover Biopharmaceuticals, Ltd. Stock Forecast 2026

The forecast for Clover Biopharmaceuticals, Ltd. (2197.HK) in 2026 suggests a price of $4.53, representing a 55.29% move from today’s price.

Average Target: $4.53

Market Outlook: bullish based on current trend indicators.

Key Drivers in 2026:

Earnings growth projections.
Competitive performance in the Healthcare.
Macroeconomic factors such as interest rates and inflation.

Clover Biopharmaceuticals, Ltd. Stock Forecast 2030

By 2030, Meyka AI projects 2197.HK could trade near $11.72, showing a potential 301.46% compared to current levels.

Average Target: $11.72

Market Outlook: bullish.

What could influence the 2030 forecast:

Technological innovation and product cycles.
Expansion into global markets.
Long-term investor sentiment toward Clover Biopharmaceuticals, Ltd..

Clover Biopharmaceuticals, Ltd. 7-Year Stock Forecast (2032–2033)

Looking 7 years ahead, the long-term forecast for 2197.HK points to a price around $15.19, which is a projected 420.19% move from today’s level.

Average Target: $15.19

Outlook: bullish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:

Global economic expansion or contraction.
Regulatory and policy environment.
Clover Biopharmaceuticals, Ltd.’s ability to maintain market leadership.